Search For "biotechnology company"
Rakuten Medical to start a Global Phase 3 Trial of Alluminox Treatment usi
Updated : 3 years ago IST
Mumbai (Maharashtra) [India], May 23 (ANI/BusinessWire India): Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™ platform, today announced that the Company has b
Read More
From crops to fuel: Praj Industries demonstrates it can use India's feedst
Updated : 3 years ago IST
The CEO and MD exuded confidence while saying the company could achieve the target of using 1 per cent sustainable aviation fuel (SAF) by all aircraft by mid-2025.
Read More
Equippp Social Impact signs pact with GMR Varalakshmi Foundation to offer
Updated : 3 years, 5 months ago IST
The statement shared with stock exchanges by the information technology firm said that Equippp shall offer the software products and services for GMR Varalakshmi Foundation for one year on mutually agreed terms.
Read More
Avesthagen consolidates its position with an innovative platform for preci
Updated : 3 years, 9 months ago IST
Mumbai (Maharashtra) [India], September 6 (ANI/NewsVoir): Avesthagen Limited, India's pioneering Systems biology genomics company, has launched AVGEN Diagnostics, the first fully integrated end-to-end personalized genetic testing service. The innovative platform employs the latest in NGS seq
Read More
Excelra partners with HotSpot Therapeutics to enhance allosteric drug disc
Updated : 4 years ago IST
Hyderabad (Telangana) [India], May 26 (ANI/PRNewswire): Excelra, a leading global data and digital insights organization, today announced a partnership with HotSpot Therapeutics Inc, a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for t
Read More
FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says
Updated : 4 years ago IST
Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).
Read More
FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Res
Updated : 4 years, 1 month ago IST
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigatio
Read More
Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of
Updated : 4 years, 1 month ago IST
Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 (ANI): Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen's exclusive terri
Read More
FDA grants Direct Biologics regenerative Medicine Advanced Therapy (RMAT)
Updated : 4 years, 1 month ago IST
Austin (Texas) [US], April 13 (ANI/PRNewswire): Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration (FDA) has awarded their EV drug product ExoFlo with a Regenera
Read More
Direct Biologics reveals successful outcomes from EXIT COVID-19 Phase II C
Updated : 4 years, 2 months ago IST
Austin [Texas], April 6 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform technology, announces topline results from its first-in-human, multicenter, Phase II double-blind, placeb
Read More
Moderna requests FDA to authorize second COVID-19 booster shot for adults
Updated : 4 years, 2 months ago IST
Washington [US], March 18 (ANI/Xinhua): American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already recei
Read More
Moderna says it has begun trial of Omicron-specific vaccine booster
Updated : 4 years, 4 months ago IST
Beijing [China], January 27 (ANI): Moderna, an American pharmaceutical and biotechnology company based in Cambridge on Wednesday (local time) announced that it has begun clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.
Read More